Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compared with placebo
NS and individual monotherapy formulations for the treatment of Seasonal Allergic Rhinitis
(subjects 12 years of age and older)